Increasing evidence supported a pivotal role of the mitogen-activated protein kinase (MAPK) in the pathogenesis, symptomatology, and treatment of depression, in particular the extracellular signal-regulated kinase (ERK) subclass of MAPKs [54]. Here, MAPK1 is linked to depressive symptom measurement.